These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 17715336)

  • 41. Altered selenium status in Huntington's disease: neuroprotection by selenite in the N171-82Q mouse model.
    Lu Z; Marks E; Chen J; Moline J; Barrows L; Raisbeck M; Volitakis I; Cherny RA; Chopra V; Bush AI; Hersch S; Fox JH
    Neurobiol Dis; 2014 Nov; 71():34-42. PubMed ID: 25014023
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Huntington's disease CAG expansion at the murine Hdh locus is unstable and associated with behavioural abnormalities in mice.
    Shelbourne PF; Killeen N; Hevner RF; Johnston HM; Tecott L; Lewandoski M; Ennis M; Ramirez L; Li Z; Iannicola C; Littman DR; Myers RM
    Hum Mol Genet; 1999 May; 8(5):763-74. PubMed ID: 10196365
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Weight loss in Huntington disease increases with higher CAG repeat number.
    Aziz NA; van der Burg JM; Landwehrmeyer GB; Brundin P; Stijnen T; ; Roos RA
    Neurology; 2008 Nov; 71(19):1506-13. PubMed ID: 18981372
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism.
    Spires TL; Grote HE; Varshney NK; Cordery PM; van Dellen A; Blakemore C; Hannan AJ
    J Neurosci; 2004 Mar; 24(9):2270-6. PubMed ID: 14999077
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinico-pathological rescue of a model mouse of Huntington's disease by siRNA.
    Wang YL; Liu W; Wada E; Murata M; Wada K; Kanazawa I
    Neurosci Res; 2005 Nov; 53(3):241-9. PubMed ID: 16095740
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Age-dependent and tissue-specific CAG repeat instability occurs in mouse knock-in for a mutant Huntington's disease gene.
    Ishiguro H; Yamada K; Sawada H; Nishii K; Ichino N; Sawada M; Kurosawa Y; Matsushita N; Kobayashi K; Goto J; Hashida H; Masuda N; Kanazawa I; Nagatsu T
    J Neurosci Res; 2001 Aug; 65(4):289-97. PubMed ID: 11494364
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease.
    Yu ZX; Li SH; Evans J; Pillarisetti A; Li H; Li XJ
    J Neurosci; 2003 Mar; 23(6):2193-202. PubMed ID: 12657678
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use of transgenic and knock-in mice to study Huntington's disease.
    Hickey MA; Chesselet MF
    Cytogenet Genome Res; 2003; 100(1-4):276-86. PubMed ID: 14526189
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dramatic mutation instability in HD mouse striatum: does polyglutamine load contribute to cell-specific vulnerability in Huntington's disease?
    Kennedy L; Shelbourne PF
    Hum Mol Genet; 2000 Oct; 9(17):2539-44. PubMed ID: 11030759
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models.
    Menalled L; El-Khodor BF; Patry M; Suárez-Fariñas M; Orenstein SJ; Zahasky B; Leahy C; Wheeler V; Yang XW; MacDonald M; Morton AJ; Bates G; Leeds J; Park L; Howland D; Signer E; Tobin A; Brunner D
    Neurobiol Dis; 2009 Sep; 35(3):319-36. PubMed ID: 19464370
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transgenic rat model of Huntington's disease.
    von Hörsten S; Schmitt I; Nguyen HP; Holzmann C; Schmidt T; Walther T; Bader M; Pabst R; Kobbe P; Krotova J; Stiller D; Kask A; Vaarmann A; Rathke-Hartlieb S; Schulz JB; Grasshoff U; Bauer I; Vieira-Saecker AM; Paul M; Jones L; Lindenberg KS; Landwehrmeyer B; Bauer A; Li XJ; Riess O
    Hum Mol Genet; 2003 Mar; 12(6):617-24. PubMed ID: 12620967
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Normal sensitivity to excitotoxicity in a transgenic Huntington's disease rat.
    Winkler C; Gil JM; Araújo IM; Riess O; Skripuletz T; von Hörsten S; Petersén A
    Brain Res Bull; 2006 Apr; 69(3):306-10. PubMed ID: 16564426
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autopsy-proven Huntington's disease with 29 trinucleotide repeats.
    Kenney C; Powell S; Jankovic J
    Mov Disord; 2007 Jan; 22(1):127-30. PubMed ID: 17115386
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decrease in striatal enkephalin mRNA in mouse models of Huntington's disease.
    Menalled L; Zanjani H; MacKenzie L; Koppel A; Carpenter E; Zeitlin S; Chesselet MF
    Exp Neurol; 2000 Apr; 162(2):328-42. PubMed ID: 10739639
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ectopic expression of the striatal-enriched GTPase Rhes elicits cerebellar degeneration and an ataxia phenotype in Huntington's disease.
    Swarnkar S; Chen Y; Pryor WM; Shahani N; Page DT; Subramaniam S
    Neurobiol Dis; 2015 Oct; 82():66-77. PubMed ID: 26048156
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The operant serial implicit learning task reveals early onset motor learning deficits in the Hdh knock-in mouse model of Huntington's disease.
    Trueman RC; Brooks SP; Jones L; Dunnett SB
    Eur J Neurosci; 2007 Jan; 25(2):551-8. PubMed ID: 17284197
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington's disease transgenic mice prior to the onset of motor symptoms.
    Hebb AL; Robertson HA; Denovan-Wright EM
    Neuroscience; 2004; 123(4):967-81. PubMed ID: 14751289
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lack of association of somatic CAG repeat expansion with striatal neurodegeneration in HD knock-in animal models.
    Bai D; Yin P; Zhang Y; Sun F; Chen L; Lin L; Yan S; Li S; Li XJ
    Hum Mol Genet; 2021 Jul; 30(16):1497-1508. PubMed ID: 33949657
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lack of huntingtin promotes neural stem cells differentiation into glial cells while neurons expressing huntingtin with expanded polyglutamine tracts undergo cell death.
    Conforti P; Camnasio S; Mutti C; Valenza M; Thompson M; Fossale E; Zeitlin S; MacDonald ME; Zuccato C; Cattaneo E
    Neurobiol Dis; 2013 Feb; 50():160-70. PubMed ID: 23089356
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dopamine enhances motor and neuropathological consequences of polyglutamine expanded huntingtin.
    Cyr M; Sotnikova TD; Gainetdinov RR; Caron MG
    FASEB J; 2006 Dec; 20(14):2541-3. PubMed ID: 17065224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.